In Boehringer Ingelheim Pharma GmbH & Co. KG v. Premchand Godha & Anr. (CS(OS) No. 1287/2013 (Del. Dec. 16, 2013)), the High Court of Delhi confirmed its injunction order of July 5, 2013, in favor of the plaintiff. The Court reiterated the strict approach adopted by the courts in determining the possibility of confusion arising from use of trademarks on pharmaceutical products. The main question in the present case was whether the trademark MUCOSOLVIN, used by the defendants since 2011 for![]()
